Skip to content

Indaptus Therapeutics, Inc.

INDP· NasdaqCore metricsCIK 1857044

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.57%
Market cap
$418.38M
133.24M shares
Filings
345
—
—
—
-$1.05M
Q3 2026N/M FY25 yoy
-$1.14M
Q3 2026N/M FY25 yoy
-$11.29M
FY 2021derived
—
-$0.01
Q3 2026N/M FY25 yoy
$26.60M
Q3 2026+47.0% FY25 yoy
$418.38M
—
—
40.5×
—
—

FY2025 figures · derived

Price

$3.14+15.44%+$0.42past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$9.34MFY 2025
$9.34M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$9,340,959reported
FY 20242024-12-31$7,251,097reported
FY 20232023-12-31$7,621,707reported
FY 20222022-12-31$6,324,657reported
FY 20212021-12-31$2,523,153reported
FY 20202020-12-31$2,655,017reported

Pharmaceutical preparations

Indaptus Therapeutics, Inc. is the 203rd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR